Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
06/2003
06/05/2003WO2003045409A1 A pharmaceutical composition made from chinese traditional medecine and method of producing thereof
06/05/2003WO2003045394A1 Succinic acid salts of 5,8,14-triazatetracyclo'10.3.1.0<2,11>.0<4,9>-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
06/05/2003WO2003045392A2 Use of n-(indolcarbonyl-)piperazine derivatives
06/05/2003WO2003045388A1 Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases
06/05/2003WO2003045384A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
06/05/2003WO2003045383A1 Use of ppar activators for the treatment of pulmonary fibrosis
06/05/2003WO2003045382A1 Therapeutic compounds for treating dyslipidemic conditions
06/05/2003WO2003045370A1 Pharmaceutical composition for treating obesity
06/05/2003WO2003045368A1 Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes
06/05/2003WO2003045362A2 Treatment of th1 dominated immunological disease states with non-endogenous gestagen compounds
06/05/2003WO2003045355A1 Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type-ii diabetes mellitus
06/05/2003WO2003045333A2 Treatment of hyperproliferative diseases using active vitamin d analogues
06/05/2003WO2003045328A2 Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof
06/05/2003WO2003045318A2 Manipulation of cytokine levels using cd83 gene products
06/05/2003WO2003045316A2 Polynucleotide therapy
06/05/2003WO2003045313A2 2-aminoquinoline compounds
06/05/2003WO2003045228A2 Methods for treating autoimmune disorders, and reagents related thereto
06/05/2003WO2003045165A1 Darreichungsformen von aleuron
06/05/2003WO2003045162A1 Method of fattening poultry
06/05/2003WO2002091988A3 Novel processes for the preparation of adenosine compounds and intermediates thereto
06/05/2003WO2002085843A3 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
06/05/2003WO2002048124A3 Piperazine derivatives
06/05/2003WO2002046230A3 G-protein coupled receptors
06/05/2003WO2002007754A3 New use
06/05/2003WO2001064899A9 Nucleotide sequences encoding proteins that take part in the biosynthesis of l-serine, improved method for microbially producing l-serine, and genetically modified microorganism suitable for use in said method
06/05/2003US20030106082 Transgenic stem cells, formed by dissociating blastomeres, are cultured, impregnated within surrogate; animals models; gene therapy
06/05/2003US20030105336 Pyrazole derivatives, their preparation and their use in pharmaceuticals
06/05/2003US20030105333 RXR activating molecules
06/05/2003US20030105331 Use as anorectics, treating obesity and type II diabetes; C2-substituent is a sulfonyl-, sulfinyl- or sulfide-containing group, and indan 1-hydroxy group is esterified, etherified or a carbonate group
06/05/2003US20030105318 G-protein transmembrane domain; protein synthesis inhibitor; neurotransmitter
06/05/2003US20030105151 Anticancer agents; antiinflammatory agents; autoimmune diseases; rheumatic diseases
06/05/2003US20030105150 Method of treating of demyelinating diseases or conditions
06/05/2003US20030105148 Selective estrogen receptor modulators
06/05/2003US20030105145 Polysubstituted indan-1-ol compounds, and methods for their preparation and use
06/05/2003US20030105142 Amide derivatives useful as inhibitors of the production of cytokines
06/05/2003US20030105135 Adrenergic receptors; gastrointestinal disorders, dietetics, urogenital disorders, antidiabetic agents
06/05/2003US20030105118 Tricyclic quinazolinediones
06/05/2003US20030105117 For therapy of affective disorder, anxiety, depression, headache, irritable bowel syndrome, post-traumatic stress stress disorder, supranuclear palsy, immune suppression, Alzheimer's disease, gastrointestinal diseases, anorexia
06/05/2003US20030105114 Methods of treatment and kits comprising a growth hormone secretagogue
06/05/2003US20030105107 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
06/05/2003US20030105106 5-HT receptor ligands and uses thereof
06/05/2003US20030105094 For therapy of metabolic disorder, an eating disorder or diabetes
06/05/2003US20030105090 For therapy of cancer, diabetes
06/05/2003US20030105087 New polycyclic azaindole compounds
06/05/2003US20030105085 Antagonists of MCP-1 function and methods of use thereof
06/05/2003US20030105078 Diphenyl derivatives
06/05/2003US20030105077 2,6-Dioxo-1,2,3,6-tetrahydropurine derivatives; dipeptidyl peptidase IV inhibitors for diabetes and obesity
06/05/2003US20030105075 Hymenialdisine or derivatives thereof in the manufacture of medicaments
06/05/2003US20030105052 Oligoribonucleotide derivatives for specific inhibition of gene expression
06/05/2003US20030105031 Administering therapeutically effective amount of one or more flavonoids and carrier for therapy of reactive and inflammatory dermatoses
06/05/2003US20030105027 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
06/05/2003US20030105024 Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
06/05/2003US20030105021 Using peptide comprising a chain of 7 to 17 contiguous amino acids derived from region of human TNF- alpha from Ser100 to Glu116 or from region of mouse TNF- alpha from Ser99 to Glu115 for manufacture of a medicament for oedema
06/05/2003US20030104992 A cyclic polypeptides; immunosuppressive anti-inflammatory activity, inhibiting antigen-induced inflammatory cell infiltration
06/05/2003US20030104983 A continuous infusion solution, consisting of buffer selected from the group TRIS and arginine, a zinc compound and a phenolic preservatives; treating diabetes, hyperglycemia
06/05/2003US20030104977 Methods for inducing angiogenesis using morphogenic proteins and stimulatory factors
06/05/2003US20030104975 Useful for identification of compounds that induce or inhibit the recruitment of the p160 family cofactors, especially TIF-2 and/ or SRCs cofactors (Translation initiation factor-2 and steroid receptor cofactors)
06/05/2003US20030104974 Dual inhibitorsof PDE 7 and PDE 4
06/05/2003US20030104596 human desaturase gene and uses thereof
06/05/2003US20030104590 Microfabricated devices for the storage and selective exposure of chemicals and devices
06/05/2003US20030104500 Enzymatic assays for screening anti-cancer agents
06/05/2003US20030104478 Screening modulators of g-protein activity: for use in treatment of nervous system disorders
06/05/2003US20030104406 Modified and stabilized GDF propeptides and uses thereof
06/05/2003US20030104399 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of body weight and aging disorders
06/05/2003US20030104081 Composition for treating obesity and esthetic treatment process
06/05/2003US20030104064 Biodegradable, resistant to salt, hardly forms spores, does not contain any plasmids; food and beverage additive; cosmetics
06/05/2003US20030104060 Fenofibrate pharmaceutical composition having high bioavailability
06/05/2003US20030104051 Fenofibrate pharmaceutical composition having high bioavailability
06/05/2003US20030104033 Contain caseinate and another protein, preferably soybean protein or whey; reduced rate of creaming and an enhanced shelf life.
06/05/2003US20030104005 Physiologically active compositions based upon active ingredients of basidiomycotina and araliaceae
06/05/2003US20030103978 Antibodies and antigen binding domains used to prevent or treat conditions relating to loss of bone mass and bone disorders; nucleic acid encoding antibodies and antigen binding domains
06/05/2003US20030103954 Comprises vitamin D3 for regulating cell differentiation and/or cell proliferation
06/05/2003US20030103953 Comprises vitamin D3 for controlling cell differentiation and/or cell proliferation
06/05/2003US20030103931 Crosslinked polylysine
06/05/2003US20030101925 Novel stable crystal of thiazolidinedione derivative and process for producing the same
06/05/2003CA2837936A1 Peptidomimetic inhibitors of post-proline cleaving enzymes
06/05/2003CA2471833A1 Methods of compositions for normalizing lipid levels in mammalian tissues
06/05/2003CA2468717A1 Aryl fused azapolycyclic compounds
06/05/2003CA2468705A1 Succinic acid salts of 5,8,14-triazatetracyclo'10.3.1.0<2,11>.0<4,9>-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
06/05/2003CA2468380A1 Use of n-(indolecarbonyl)piperazine derivatives
06/05/2003CA2468301A1 Method of fattening poultry
06/05/2003CA2468280A1 Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes
06/05/2003CA2468192A1 Peptidomimetic inhibitors of post-proline cleaving enzymes
06/05/2003CA2468184A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
06/05/2003CA2468159A1 4-aminoquinoline compounds
06/05/2003CA2468135A1 Ginger extract preparation
06/05/2003CA2468020A1 Osteopontin-related compositions and methods
06/05/2003CA2468015A1 2-aminoquinoline compounds
06/05/2003CA2467892A1 Methods and compositions for derepression of iap-inhibited caspase
06/05/2003CA2467664A1 Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof
06/05/2003CA2467565A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
06/05/2003CA2467165A1 Therapeutic compounds for treating dyslipidemic conditions
06/05/2003CA2466870A1 Methods for treating autoimmune disorders, and reagents related thereto
06/05/2003CA2466867A1 Treatment of hyperproliferative diseases using active vitamin d analogues
06/05/2003CA2466845A1 Manipulation of cytokine levels using cd83 gene products
06/05/2003CA2466677A1 Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type-ii diabetes mellitus
06/05/2003CA2435758A1 Polynucleotide therapy_against autoantigens for treating insulin dependent diabetes mellitus
06/04/2003EP1316611A1 L-methionine gamma-lyase with modified function
06/04/2003EP1316552A1 Processing method of lactonization in the preparation of statins
06/04/2003EP1316548A1 Acylsulfonamide derivatives
1 ... 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 ... 1298